First Trust Tactical High Yield ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HYLS and other ETFs, options, and stocks.

About HYLS

HYLS is an actively managed fund holding up to 130% in long positions in high yield bonds it expects to outperform, and up to 30% short positions in issues it expects to underperform. The listed name for HYLS is First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF. 

Index-Tracked
Index-Tracked
Category
High Yield Bond
CategoryHigh Yield Bond
Number of holdings
334
Number of holdings334
Inception Date
Feb 25, 2013
Inception DateFeb 25, 2013

What's in this fund

Sectors

As of April 22, 2025
Corporate Bonds99.92%
Cash and Equivalents0.08%

Top 10 Holdings (14.40% of total assets)

As of April 22, 2025
NameSymbol% Assets
1011778 B.C. Unlimited Liability Company / New Red Finance, Inc. 4%1.90%
Graham Packaging Company Inc 7.125%1.89%
United Rentals (North America), Inc. 6%1.62%
SS&C Technologies, Inc. 5.5%1.57%
Truist Insurance Holdings LLC & Panther Co-Issuer Inc. 7.125%1.33%
Ardonagh Finco Ltd. 7.75%1.27%
Cotiviti Inc 7.625%, Due 5/1/20311.23%
Baldwin Insurance Group Holdings LLC / Baldwin Insurance Group Holdings Fin1.21%
Acrisure Llc / Acrisure Fin Inc 7.5%1.20%
Clarios Global LP 8.5%1.18%

HYLS Key Statistics

AUM
1.64B
AUM1.64B
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
6.49
30-Day yield6.49
Average volume
217.34K
Average volume217.34K
High today
$41.00
High today$41.00
Low today
$40.69
Low today$40.69
Open price
$40.72
Open price$40.72
Volume
147.34K
Volume147.34K
52 Week high
$42.55
52 Week high$42.55
52 Week low
$39.49
52 Week low$39.49
Expense ratio
1.05
Expense ratio1.05

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.